I think the story is... that the story kept changing. Thankfully,
@drgarymcgowan took some screenshots.
And I personally think that when a research group prioritises the release of a slick documentary and the establishment of a lucrative brand over basic quality control, the integrity of the data will always become a secondary concern.
I don’t think they were ever interested in quality control
@StevenQuartz. They didn’t even bother with a preprint. The decision to bypass a preprint, especially when launching a massive public relations and documentary campaign to me is telling.
In modern clinical research, preprints should serve as a crucial public sandbox for early peer scrutiny. If an anomaly exists in a dataset, posting a preprint allows the community to inspect the preliminary data, catch the oddities, and raise red flags before a paper receives formal journal publication. Wouldn't you want that before releasing a slick and expensive documentary about this study?
By skipping the preprint stage and rushing straight to publication to align with a film premiere schedule, a safety net might have been deliberately removed. The timeline prioritised maximum media impact on "launch day" over scientific vetting.
And the media vehicle was already rolling, the documentary had even been premiered before the publishing of the study. Maybe, when a film, a brand and a narrative are locked to a public release schedule, the scientific timeline gets crushed by commercial deadlines? Feldman has acknowledged surprise at the NCPV numbers prior to publication. And then simultaneously attempted to downplay the discrepancy post publication. This is fundamentally backwards. The excellent post by
@ChrisVMDHealth with regards to publishing day peacocking is worth a read.
We witnessed a masterclass in conflict of interest and performative science. The NCPV figures returned by Cleerly were biologically startling. Anybody in the know, knew that. Seeing an average NCPV progression rate almost four times higher than expected in normal cohorts should have triggered an immediate pause by the authors. It didn’t. They went full steam ahead, hoping nobody would notice the anomalies. And now hoping you only notice the Cleerly anomalies… to deflect you from noticing the manuscript anomalies in both the retracted manuscript and it’s equally anomalous and mischievous preprint. If any of the authors mention “Cleerly”, this is simply “deflection” tactics.
And now we do have a preprint. Because in all truth, that’s all it can ever be. And nine months later that preprint still hasn’t been amended, peer reviewed and published. And if I was a top journal, I’d be inclined to avoid it, knowing that peer review is not what it should be. And
@JACCJournals is a good example as peer review obviously failed massively here.
That the documentary's scientific backbone is based on a mischievous stranded preprint is startling to me. If you haven’t watched the
@JohnSloughII and
@TheCalvinWest YouTubes, I recommend you do. They are fascinating and damning of both manuscripts.
And it could even be that John Slough's "letter of concerns" to the editor is the real reason for the retraction. Only that
@JACCJournals could never admit to that. Formal journals rarely send out press releases or emails thanking independent sleuths for doing the editorial board's job for them. Institutional pride dictates a cleaner, more bureaucratic exit strategy, like framing the retraction around the "author requests" or "post publication re evaluations" to preserve whatever dignity the peer review apparatus has left. We'll probably never know the truth.
And, I think that post retraction preprint functions as an exercise in damage control rather than transparent science. It created an illusion of scientific legitimacy for lay audiences for the documentary who do not or cannot distinguish between an unvetted preprint and a peer reviewed journal publication.
Even worse, Feldman is now trying to outsource accountability for that retracted paper.
Well, you can’t. You cannot outsource accountability for your work, your study.
You can outsource the work, but you cannot outsource “accountability”. Most good journals require authors to sign a statement declaring they had full access to all study data and take full responsibility for its integrity. This is in line with the ICMJE accountability. And the university where I reside, we teach students that as authors, they are fully accountable for all aspects of the work. Including the third party data transfers, work and tasks. And that is because a lot of today's science requires third parties. Science has grown far too complex for any single research group to build every tool from scratch.
Attempting to outsource scientific accountability to a third party vendor is not merely a weak defence, it is a fundamental violation of the core tenets of academic authorship. I find that shameful from Feldman, and this is how I know he is not a bonafide investigator. Attempting to claim all the glory of a "groundbreaking" public relations blitz on launch day, only to turn around and blame the software vendor when independent analysts dismantle the paper, is the ultimate display of intellectual dishonesty.
And let's not forget that peacocking by Feldman and the authors on launch day. And never forget the final frames of the video by Feldman on that day in his favourite blue shirt as it funnels traffic directly to a proprietary film website.
The documentary should be titled "The Cholesterol Code Con".
piped.video/watch?v=HJJGHQDE…